Psychedelic stocks are on the rise. Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness...
The exact number of shares to be sold will be determined by Numinus' financier. The post Numinus to Sell C$10M Worth of New Shares Through Equity...
The import to Filament’s Metro Vancouver facility was conducted in collaboration with the Peruvian government and facilitated by Filament Health and...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Beckley Waves raises $3.3 million, capital to be used for investing in startups focused on infrastructure and services for psychedelic therapies. The post...
The initiative has already helped fund two research programs in Sweden. The post Swedish Nonprofit Announces $3 Million in Funding for Psychedelic Studies...
The initiative has already helped fund two research programs in Sweden. The post Swedish Nonprofit Announces $3 Million in Funding for Psychedelic Startups...
In November 2022, Lusaris Therapeutics made news for its $60 million Series A round. Since then, there has been a curious silence from the company. We...
Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the ‘Company’ or ‘Psyched’), a life sciences company focused on the production and...
Awakn Life Sciences has submitted a Clinical Trial Application for a phase III trial for its lead program for the treatment of Severe Alcohol Use Disorder....